ALX vs CBL

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score due to insufficient data. Despite strong profitability metrics like high ROE and gross margin, the company faces significant risks including an extremely high debt/equity ratio of 7.86, negative earnings growth, and a dangerously high payout ratio of 252.10%, which raises sustainability concerns. The stock is trading at $243.04, far above both the Graham Number ($63.22) and intrinsic value estimate ($49.49), suggesting severe overvaluation. While recent price performance has been strong over the past year, weak fundamentals and deteriorating growth trends point to elevated downside risk.

CBL presents a paradoxical profile with a stable Piotroski F-Score of 4/9 and explosive short-term growth, contrasted by critical liquidity risks. While the company boasts a high ROE of 39.71% and strong 1-year price performance, its balance sheet is severely stressed with a Current Ratio of 0.14 and a Debt/Equity ratio of 5.95. The discrepancy between the low trailing P/E (10.22) and the negative Forward P/E (-113.72) suggests a looming earnings cliff. Consequently, the stock is viewed as a high-risk recovery play rather than a stable value investment.